Cirrhotic rats with bacterial translocation have higher incidence and severity of hepatopulmonary syndrome

Journal of Gastroenterology and Hepatology (Australia)

Volumn 20, Issue 10, 2005, Pages 1538-1544

  Sztrymf, Benjamin ^a   Libert, Jean Marie ^a   Mougeot, Christine ^a   Lebrec, Didier ^b   Mazmanian, Michel ^a   Humbert, Marc ^a   Herve, Philippe ^a  

^a CENTRE CHIRURGICAL MARIE LANNELONGUE   (France)

^b BEAUJON HOSPITAL   (France)

Author keywords

Bacterial translocation; Cirrhosis; Hepatopulmonary syndrome; Macrophage; Tumor necrosis factor alpha

Indexed keywords

NORFLOXACIN; PENTOXIFYLLINE; TUMOR NECROSIS FACTOR ALPHA; OXYGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL OXYGEN TENSION; ARTICLE; BACTERIAL TRANSLOCATION; BACTERIUM CULTURE; BILE DUCT LIGATION; BLOOD LEVEL; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HEPATOPULMONARY SYNDROME; INCIDENCE; INTESTINE FLORA; LIVER CIRRHOSIS; LUNG ARTERIOVENOUS SHUNT; LUNG BLOOD VESSEL; MACROPHAGE; MALE; MESENTERY LYMPH NODE; MORPHOMETRICS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RAT; ANIMAL; ARTERY; BLOOD; BLOOD VESSEL; HOSPITALIZATION; LUNG; LUNG ALVEOLUS; METABOLISM; MICROBIOLOGY; OSMOLARITY; PATHOLOGY; PATHOPHYSIOLOGY; VASCULARIZATION; WISTAR RAT;

ANIMALS; ARTERIES; BACTERIAL TRANSLOCATION; BLOOD VESSELS; HEPATOPULMONARY SYNDROME; INCIDENCE; LIVER CIRRHOSIS; LUNG; MACROPHAGES; MALE; OSMOLAR CONCENTRATION; OXYGEN; PULMONARY ALVEOLI; RATS; RATS, WISTAR; SEVERITY OF ILLNESS INDEX; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33644700812     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2005.03914.x     Document Type: Article

References (41)

1. Cirera I, Bauer TM, Navasa M et al. Bacterial translocation of enteric organisms in patients with cirrhosis. J. Hepatol. 2001 34 : 32 7.
2. Sakrak O, Akpinar M, Bedirli A, Akyurek N, Aritas Y. Short and long-term effects of bacterial translocation due to obstructive jaundice on liver damage. Hepatogastroenterology 2003 50 : 1542 6.
3. Llovet JM, Bartoli R, Planas R et al. Bacterial translocation in cirrhotic rats. Its role in the development of spontaneous bacterial peritonitis. Gut 1994 35 : 1648 52.
4. Runyon BA, Squier S, Borzio M. Translocation of gut bacteria in rats with cirrhosis to mesenteric lymph nodes partially explains the pathogenesis of spontaneous bacterial peritonitis. J. Hepatol. 1994 21 : 792 6.
5. Runyon BA, Borzio M, Young S et al. Effect of selective bowel decontamination with norfloxacin on spontaneous bacterial peritonitis, translocation, and survival in an animal model of cirrhosis. Hepatology 1995 21 : 1719 24.
6. Garcia-Tsao G, Lee FY, Barden GE et al. Bacterial translocation to mesenteric lymph nodes is increased in cirrhotic rats with ascites. Gastroenterology 1995 108 : 1835 41.
7. Genesca J, Marti R, Rojo F et al. Increased tumour necrosis factor alpha production in mesenteric lymph nodes of cirrhotic patients with ascites. Gut 2003 52 : 1054 9.
8. Wiest R, Das S, Cadelina G et al. Bacterial translocation in cirrhotic rats stimulates eNOS-derived NO production and impairs mesenteric vascular contractility. J. Clin. Invest. 1999 104 : 1223 33.
9. Rasaratnam B, Kaye D, Jennings G et al. The effect of selective intestinal decontamination on the hyperdynamic circulatory state in cirrhosis. A randomized trial. Ann. Intern. Med. 2003 139 : 186 93.
10. Nakatani Y, Fukui H, Kitano H et al. Endotoxin clearance and its relation to hepatic and renal disturbances in rats with liver cirrhosis. Liver 2001 21 : 64 70.
11. Liu H, Ma Z, Lee SS. Contribution of nitric oxide to the pathogenesis of cirrhotic cardiomyopathy in bile duct-ligated rats. Gastroenterology 2000 118 : 937 44.
12. Ferraz JG, Wallace JL. Underlying mechanisms of portal hypertensive gastropathy. J. Clin. Gastroenterol. 1997 25 : S73 8.
13. Dunn CW, Horton JW, Megison SM et al. Contribution of portal systemic shunt to Kupffer cell dysfunction in obstructive jaundice. J. Surg. Res. 1991 50 : 234 9.
14. Hoshino S, Sun Z, Uchikura K et al. Biliary obstruction reduces hepatic killing and phagocytic clearance of circulating microorganisms in rats. J. Gastrointest. Surg. 2003 7 : 497 506.
15. Tomioka M, Iinuma H, Okinaga K. Impaired Kupffer cell function and effect of immunotherapy in obstructive jaundice. J. Surg. Res. 2000 92 : 276 82.
16. Panos RJ, Baker SK. Mediators, cytokines, and growth factors in liver-lung interactions. Clin. Chest Med. 1996 17 : 151 69.
17. Katz S, Grosfeld JL, Gross K et al. Impaired bacterial clearance and trapping in obstructive jaundice. Ann. Surg. 1984 199 : 14 20.
18. Chang SW, Ohara N. Increased pulmonary vascular permeability in rats with biliary cirrhosis: role of thromboxane A2. Am. J. Physiol. 1993 264 : L245 52.
19. Chang SW, Ohara N. Chronic biliary obstruction induces pulmonary intravascular phagocytosis and endotoxin sensitivity in rats. J. Clin. Invest. 1994 94 : 2009 19.
20. Chang SW, Ohara N. Pulmonary intravascular phagocytosis in liver disease. Clin. Chest Med. 1996 17 : 137 50.
21. Miot-Noirault E, Faure L, Guichard Y et al. Scintigraphic in vivo assessment of the development of pulmonary intravascular macrophages in liver disease: experimental study in rats with biliary cirrhosis. Chest 2001 120 : 941 7.
22. Nunes H, Lebrec D, Mazmanian M et al. Role of nitric oxide in hepatopulmonary syndrome in cirrhotic rats. Am. J. Respir. Crit. Care Med. 2001 164 : 879 85.
23. Sztrymf B, Rabiller A, Nunes H et al. Prevention of hepatopulmonary syndrome by pentoxifylline in cirrhotic rats. Eur. Respir. J. 2004 23 : 752 8.
24. Strieter RM, Kunkel SL, Keane MP et al. Chemokines in lung injury: Thomas A. Neff lecture. Chest 1999 116 : 103S 110S.
25. Olson TS, Ley K. Chemokines and chemokine receptors in leukocyte trafficking. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2002 283 : R7 28.
26. Chang SW, Ohara N. Pulmonary circulatory dysfunction in rats with biliary cirrhosis. An animal model of the hepatopulmonary syndrome. Am. Rev. Respir. Dis. 1992 145 : 798 805.
27. Fallon MB, Abrams GA, McGrath JW et al. Common bile duct ligation in the rat: a model of intrapulmonary vasodilatation and hepatopulmonary syndrome. Am. J. Physiol. 1997 272 : G779 84.
28. Schraufnagel DE, Kay JM. Structural and pathologic changes in the lung vasculature in chronic liver disease. Clin. Chest Med. 1996 17 : 1 15.
29. Zhang J, Ling Y, Luo B et al. Analysis of pulmonary heme oxygenase-1 and nitric oxide synthase alterations in experimental hepatopulmonary syndrome. Gastroenterology 2003 125 : 1441 51.
30. MacMicking J, Xie QW, Nathan C. Nitric oxide and macrophage function. Annu. Rev. Immunol. 1997 15 : 323 50.
31. Oguro T, Takahashi Y, Ashino T et al. Involvement of tumor necrosis factor alpha, rather than interleukin-1alpha/beta or nitric oxides in the heme oxygenase-1 gene expression by lipopolysaccharide in the mouse liver. FEBS Lett. 2002 516 : 63 6.
32. Gross SS, Jaffe EA, Levi R et al. Cytokine-activated endothelial cells express an isotype of nitric oxide synthase which is tetrahydrobiopterin- dependent, calmodulin-independent and inhibited by arginine analogs with a rank-order of potency characteristic of activated macrophages. Biochem. Biophys. Res. Commun. 1991 178 : 823 9.
33. Terry CM, Clikeman JA, Hoidal JR et al. Effect of tumor necrosis factor-alpha and interleukin-1 alpha on heme oxygenase-1 expression in human endothelial cells. Am. J. Physiol. 1998 274 : H883 91.
34. Rabiller A, Nunes H, Lebrec D et al. Prevention of gram-negative translocation reduces the severity of hepatopulmonary syndrome. Am. J. Respir. Crit. Care Med. 2002 166 : 514 17.
35. Barbe T, Losay J, Grimon G et al. Pulmonary arteriovenous shunting in children with liver disease. J. Pediatr. 1995 126 : 571 9.
36. Luo B, Liu L, Tang L, Zhang J, Ling Y, Fallon MB. ET-1 and TNF-alpha in HPS: analysis in prehepatic portal hypertension and biliary and nonbiliary cirrhosis in rats. Am. J. Physiol. Gastrointest. Liver Physiol. 2004 286 : G294 303.
37. Lopez-Talavera JC, Merrill WW, Groszmann RJ. Tumor necrosis factor alpha: a major contributor to the hyperdynamic circulation in prehepatic portal-hypertensive rats. Gastroenterology 1995 108 : 761 7.
38. Ieuwenhuijs VB, van Dijk JE, Gooszen HG, Akkermans LM. Obstructive jaundice, bacterial translocation and interdigestive small-bowel motility in rats. Digestion 2000 62 : 255 61.
39. Kuzu MA, Kale IT, Col C, Tekeli A, Tanik A, Koksoy C. Obstructive jaundice promotes bacterial translocation in humans. Hepatogastroenterology 1999 46 : 2159 64.
40. Teisseyre M, Szymczak M, Swiatek-Rawa E et al. Scintiscanning in diagnostics of hepatopulmonary syndrome in children. Med. Sci. Monit. 2001 7 (Suppl. 1 255 61.
41. Anel RM, Sheagren JN. Novel presentation and approach to management of hepatopulmonary syndrome with use of antimicrobial agents. Clin. Infect. Dis. 2001 32 : E131 6.